Inverse Relationship of Serum Hepcidin Levels with CD4 Cell Counts in HIV-Infected Patients Selected from an Indonesian Prospective Cohort Study
Open accessThe DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Distortion of iron homeostasis may contribute to the pathogenesis of human immunodeficiency virus (HIV) infection and tuberculosis (TB). We studied the association of the central iron-regulatory hormone hepcidin with the severity of HIV and the association between hepcidin and other markers of iron homeostasis with development of TB. METHODS: Three groups of patients were selected from a prospective cohort of HIV-infected subjects in Bandung, Indonesia. The first group consisted of HIV-infected patients who started TB treatment more than 30 days after cohort enrollment (cases). The second group consisted of HIV-infected patients who were matched for age, gender and CD4 cell count to the cases group (matched controls). The third group consisted of HIV-infected patients with CD4 cell counts above 200 cells/mm(3) (unmatched controls). Iron parameters including hepcidin were compared using samples collected at cohort enrollment, and compared with recently published reference values for serum hepcidin. RESULTS: A total of 127 HIV-infected patients were included, 42 cases together with 42 matched controls and 43 unmatched controls. Patients with advanced HIV infection had elevated serum hepcidin and ferritin levels. Hepcidin levels correlated inversely with CD4 cells and hemoglobin. Cases had significantly higher hepcidin and ferritin concentrations at cohort enrollment compared to matched controls, but these differences were fully accounted for by the cases who started TB treatment between day 31 and 60 after enrollment. Hepcidin levels were not different in those with or without hepatitis C infection. CONCLUSION: Iron metabolism is distorted in advanced HIV infection with CD4 cell counts correlating inversely with serum hepcidin levels. High serum hepcidin levels and hyperferritinemia were found in patients starting TB treatment shortly after cohort enrollment, suggesting that these parameters have a predictive value for development of manifest TB in HIV-infected patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“For example, it is upregulated during uncomplicated malaria [23–26], and during acute, chronic and advanced HIV-1 infection [27,28];”
From Rapidly Escalating Hepcidin and Associated Serum Iron Starvation Are Features of the Acute Response to Typhoid Infection in Humans (2015) · cites this paper as [28]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hepcidin Regulates Cellular Iron Efflux by Binding to Ferroportin and Inducing Its Internalization
Nemeth, E., Tuttle, M. S., Powelson, J., Vaughn, M. B., Donovan, A., Ward, D. M., Ganz, T., & Kaplan, J. (2004) · Science · doi:10.1126/science.1104742 · Cited by 4,803 · cited 2×
“Hepcidin degrades the sole cellular iron exporter ferroportin leading to reduced iron absorption in the intestine and iron retention in monocytes and macrophages and the spleen [2].”
BackgroundHepcidin and iron regulation, 10 years later
Ganz, T. (2011) · Blood · doi:10.1182/blood-2011-01-258467 · Cited by 962 · cited 1×
“Alterations in iron distribution are common in infectious diseases and many of these alterations may be attributable to actions of the iron-regulatory hormone hepcidin [1].”
BackgroundThe WHO public-health approach to antiretroviral treatment against HIV in resource-limited settings
Gilks, C. F., Crowley, S., Ekpini, R., Gove, S., Perriens, J., Souteyrand, Y., Sutherland, D., Vitoria, M., Guerma, T., & De Cock, K. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69158-7 · Cited by 689
Suppression of hepcidin during anemia requires erythropoietic activity
Pak, M., Lopez, M. A., Gabayan, V., Ganz, T., & Rivera, S. (2006) · Blood · doi:10.1182/blood-2006-06-028787 · Cited by 472 · cited 1×
“HIV can directly infect bone marrow progenitor cells leading to bone marrow suppression, which is associated with upregulated hepcidin expression [27,28].”
BackgroundViral infection and iron metabolism
Drakesmith, H., & Prentice, A. (2008) · Nature Reviews Microbiology · doi:10.1038/nrmicro1930 · Cited by 469 · cited 1×
“HIV replication involves several iron-dependent steps [5,6], and as a central determinant of macrophage iron contents, hepcidin may play a distinct role in HIV pathogenesis.”
BackgroundSerum hepcidin: reference ranges and biochemical correlates in the general population
Galesloot, T. E., Vermeulen, S. H., Geurts-Moespot, A. J., Klaver, S. M., Kroot, J. J., van Tienoven, D., Wetzels, J. F. M., Kiemeney, L. A. L. M., Sweep, F. C., den Heijer, M., et al. (2011) · Blood · doi:10.1182/blood-2011-02-337907 · Cited by 303 · cited 1×
“Our primary aim was to study the effect HIV infection on serum hepcidin levels and other markers of iron homeostasis and to compare hepcidin levels with recently determined reference levels for hepcidin in healthy Dutch volunteers [18].”
BackgroundSelf-citationBelperio, P. S., & Rhew, D. C. (2004) · The American Journal of Medicine · doi:10.1016/j.amjmed.2003.12.010 · Cited by 278 · cited 1×
“This may contribute to HIV-associated anemia, which is a common complication of advanced HIV infection with negative impact on clinical outcome and quality of life [8–11].”
BackgroundAnemia in HIV Infection: Clinical Impact and Evidence-Based Management Strategies
Volberding, P. A., Levine, A. M., Dieterich, D., Mildvan, D., Mitsuyasu, R., Saag, M., & for the Anemia in HIV Working Group (2004) · Clinical Infectious Diseases · doi:10.1086/383031 · Cited by 267 · cited 1×
“This may contribute to HIV-associated anemia, which is a common complication of advanced HIV infection with negative impact on clinical outcome and quality of life [8–11].”
BackgroundExpression and localization of hepcidin in macrophages: a role in host defense against tuberculosis
Sow, F. B., Florence, W. C., Satoskar, A. R., Schlesinger, L. S., Zwilling, B. S., & Lafuse, W. P. (2007) · Journal of Leukocyte Biology · doi:10.1189/jlb.0407216 · Cited by 229 · cited 2×
“tuberculosis infection to represent a host defense mechanism [14,29].”
BackgroundThe Effect of the Host’s Iron Status on Tuberculosis
Boelaert, J. R., Vandecasteele, S. J., Appelberg, R., & Gordeuk, V. R. (2007) · The Journal of Infectious Diseases · doi:10.1086/518040 · Cited by 217
Cited by
Iron, anemia and hepcidin in malaria
Spottiswoode, N., Duffy, P. E., & Drakesmith, H. (2014) · Frontiers in Pharmacology · doi:10.3389/fphar.2014.00125 · Cited by 127
Complex Anemia in Tuberculosis: The Need to Consider Causes and Timing When Designing Interventions
Minchella, P. A., Donkor, S. A., Owolabi, O., Sutherland, J. S., & McDermid, J. M. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu945 · Cited by 103
Distinct patterns of hepcidin and iron regulation during HIV-1, HBV, and HCV infections
Armitage, A. E., Stacey, A. R., Giannoulatou, E., Marshall, E., Sturges, P., Chatha, K., Smith, N. M. G., Huang, X., Xu, X., Pasricha, S.-R., et al. (2014) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1402351111 · Cited by 101
“Hepcidin inversely correlates with CD4 counts in individuals with advanced HIV-1 (19).”
BackgroundAnemia, Iron Status, and HIV: A Systematic Review of the Evidence.
Abioye, A., Andersen, C., Sudfeld, C., & Fawzi, W. (2020) · Advances in Nutrition · doi:10.1093/advances/nmaa037 · Cited by 72
“The concentration of sTfR also did not significantly differ among patients with incident TB compared with those without incident TB in a matched case-control study among injection drug users in Indonesia (76).”
BackgroundMethodResultInfluentialKerkhoff, A. D., Meintjes, G., Burton, R., Vogt, M., Wood, R., & Lawn, S. D. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv364 · Cited by 63
“While a small number of clinical studies have demonstrated an association between elevated hepcidin concentrations and tuberculosis [12, 21, 22], much of our knowledge regarding the role of hepcidin in tuberculosis has been derived from studies conducted in vitro or in animal models.”
Darton, T. C., Blohmke, C. J., Giannoulatou, E., Waddington, C. S., Jones, C., Sturges, P., Webster, C., Drakesmith, H., Pollard, A. J., & Armitage, A. E. (2015) · PLOS Neglected Tropical Diseases · doi:10.1371/journal.pntd.0004029 · Cited by 45
Minchella, P. A., Armitage, A. E., Darboe, B., Jallow, M. W., Drakesmith, H., Jaye, A., Prentice, A. M., & McDermid, J. M. (2015) · The Journal of Nutrition · doi:10.3945/jn.114.203158 · Cited by 39
“Although data regarding hepcidin in HIV infection remain limited, the findings from this study support those of an Indonesian study that reported that serum hepcidin was positively correlated with ferritin and inversely correlated with hemoglobin and absolute CD4 cell counts (15).”
BackgroundResultInfluentialAbsolute and functional iron deficiency: Biomarkers, impact on immune system, and therapy.
Iriarte-Gahete, M., Tarancón-Díez, L., Garrido-Rodríguez, V., Leal, M., & Pacheco, Y. (2024) · Blood reviews · doi:10.1016/j.blre.2024.101227 · Cited by 33
Abreu, R. B., Essler, L., Loy, A., Quinn, F. D., & Giri, P. K. (2018) · Scientific Reports · doi:10.1038/s41598-018-25480-y · Cited by 40
Essential trace elements and progression and management of HIV infection
Shah, K. K., Verma, R., Oleske, J. M., Scolpino, A. J., & Bogden, J. D. (2019) · Nutrition Research · doi:10.1016/j.nutres.2019.08.001 · Cited by 31
Duguma, N., Kiya, G. T., Adissu, W., & Gedefaw, L. (2021) · SAGE Open Medicine · doi:10.1177/20503121211020175 · Cited by 29
Inflammation in HIV Study Group, Quirós-Roldán, E., Castelli, F., Lanza, P., Pezzoli, C., Vezzoli, M., Biasiotto, G., & Zanella, I. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1358-6 · Cited by 30
“Several studies in HIV-infected patients have found an inverse association between hepcidin and absolute CD4+ cell count [17, 21], suggesting that elevated hepcidin may be ascribed to advanced disease stage and elevated levels of inflammation.”
BackgroundPathophysiology of Iron Homeostasis during Inflammatory States
Cherayil, B. J. (2015) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2015.07.015 · Cited by 28
“Nevertheless, serum or urine hepcidin levels have been shown to be significantly elevated in a number of human inflammatory conditions, including IBD, rheumatoid arthritis, malaria, human immunodeficiency virus infection and neonatal sepsis (19-22,44-47).”
BackgroundMinchella, P. A., Armitage, A. E., Darboe, B., Jallow, M. W., Drakesmith, H., Jaye, A., Prentice, A. M., & McDermid, J. M. (2014) · The International Journal of Tuberculosis and Lung Disease · doi:10.5588/ijtld.14.0143 · Cited by 24
Serum hepcidin in infants born after 32 to 37 wk of gestational age
Uijterschout, L., Domellöf, M., Berglund, S. K., Abbink, M., Vos, P., Rövekamp, L. W., Boersma, B., Lagerqvist, C., Hudig, C., van Goudoever, J. B., et al. (2015) · Pediatric Research · doi:10.1038/pr.2015.258 · Cited by 20
Dual role of hepcidin in response to pathogens
Navidifar, T., Meftah, E., Baghsheikhi, H., Kazemzadeh, K., Karimi, H., & Rezaei, N. (2025) · Microbial Pathogenesis · doi:10.1016/j.micpath.2025.107496 · Cited by 15
Somia, I., Merati, T., Bakta, I., Manuaba, I. B. P. P., Yasa, W. P. S., Sukrama, I. D. M., Suryana, K., & Wisaksana, R. (2019) · HIV/AIDS · doi:10.2147/hiv.s195483 · Cited by 11
“Moreover, hepcidin levels were found to be inversely related to the levels of CD4 cell count in the advanced stages of HIV.16 Therefore, this study aimed to determine whether high levels of serum IL-6 and hepcidin and CD4 350 cells/µL were risk factors for ACD in PLWH on cARV therapy with successful clinically and imm…”
BackgroundResultSelf-citationTashiro, K., Yamamoto, M., Ushio, R., Kobayashi, N., Sato, T., Kudo, M., & Kaneko, T. (2019) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2019.06.023 · Cited by 13
Risk factors and prognosis of thrombocytopenia in people living with HIV/AIDS
Lv, X., Li, P., Yue, P., Tang, P., & Zhou, F. (2023) · Therapeutic Advances in Hematology · doi:10.1177/20406207231170513 · Cited by 12
Dysregulation of iron metabolism modulators in virologically suppressed HIV-infected patients
Garrido‐Rodríguez, V., Álvarez‐Ríos, A. I., Olivas‐Martínez, I., Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Leal, M., & Pacheco, Y. M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.977316 · Cited by 13
Liu, Y., Lv, Q., Gao, J., Long, L., Duan, Z., Liang, H., Shen, T., & Lu, F. (2014) · PLoS ONE · doi:10.1371/journal.pone.0098039 · Cited by 12
“For example, it is known that for infants, anemia prevalence and serum ferritin level decrease after HAART without routine iron supplementation [33].”
BackgroundPérez-Peiró, M., Alvarado, M., Martín‐Ontiyuelo, C., Durán, X., Rodriguez, D. A., & Barreiro, E. (2022) · Nutrients · doi:10.3390/nu14193929 · Cited by 13
Shrivastav, V. N., Yogesh, M., Ramachandran, A., Makwana, N. R., & Parmar, D. (2025) · BMC Infectious Diseases · doi:10.1186/s12879-025-10941-3 · Cited by 10
Huibers, M. H. W., Calis, J. C. J., Allain, T. J., Coupland, S. E., Phiri, C. T., Phiri, K. S., Swinkels, D. W., van Hensbroek, M. B., & Bates, I. (2020) · PLoS ONE · doi:10.1371/journal.pone.0218694 · Cited by 8
“Reasons for the poor performances of sTfR in our population may be the lack of clear cut-offs, as suggested by other studies [10], and the fact that sTfR is also influenced by erythropoietin, which may play an important role in severe HIV-associated anaemia [38].”
BackgroundResultSelf-citationGatechompol, S., Kerr, S. J., Cardoso, S. W., Samaneka, W. P., Tripathy, S. P., Godbole, S., Ghate, M., Kanyama, C., Nyirenda, M., Sugandhavesa, P., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003713 · Cited by 8
Szymczak, A., Zalewska, M., Rymer, W., & Jankowska, E. A. (2021) · Infectious Diseases and Therapy · doi:10.1007/s40121-021-00560-1 · Cited by 7
“Therefore, iron metabolism disturbances reported in the PLWH may be limited to the advanced HIV infection stages with intense inflammatory activation, or more related to concomitant conditions being the consequences of deep immune deficiency, such as active tuberculosis [23].”
BackgroundIron status among HIV ‐infected adults during the first year of antiretroviral therapy in Tanzania
Abioye, A. I., Sudfeld, C. R., Hughes, M. D., Aboud, S., Muhihi, A. J., Ulenga, N. K., Nagu, T. J., Wang, M., Mugusi, F. M., & Fawzi, W. W. (2022) · HIV Medicine · doi:10.1111/hiv.13396 · Cited by 7
“On the other hand, elevated iron status increases the availability of iron for HIV replication and other pathogens; elevated iron status has also been shown to be associated with increased risk of all-cause mortality [7, 8], the incidence of opportunistic infections, including tuberculosis [9, 10], and failure of tube…”
BackgroundThe West African Sorghum Bicolor Leaf Sheath Extract Jobelyn® and Its Diverse Therapeutic PotentialsPreprint
Makanjuola, S., Okubena, O., Ajonuma, L. C., Dosunmu, A. O., Umukoro, S., & Erah, P. O. (2017) · Preprints.org · doi:10.20944/preprints201712.0036.v1 · Cited by 7
“HAART restores the immunologic function [37], but does not eliminate weight loss, micronutrient deficiency and wasting syndrome [38], which are strong independent predictors of mortality [39].”
BackgroundGayatri, A. A. A. Y., & Nugraha, P. P. P. (2025) · Intisari Sains Medis · doi:10.15562/ism.v16i1.2282 · Cited by 4
Armitage, A. E., & Moran, E. (2015) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiv365 · Cited by 4
“[20, 21], consistent with the present report.”
BackgroundThe Effects of Treatment on Serum Hepcidin and Iron Homeostasis in HIV-1-Infected In-dividuals
da Cunha, J., Maselli, L. M. F., Ferreira, J. D. S., Spada, C., & Bydlowski, S. P. (2015) · World Journal of AIDS · doi:10.4236/wja.2015.53018 · Cited by 2
“The observed positive correlation between serum hepcidin levels and CD4 T-cells in the ART-naive group, but not in the groups receiving HAART, is different than the results obtained by Wisaksana and colleagues (2013) [20], who conducted studies on Indonesian individuals infected with HIV and tuberculosis (TB) concomit…”
ResultKhondakar, N. R., & Finkelstein, J. L. (2018) · CRC Press eBooks · doi:10.1201/9781351058193-3 · Cited by 3
Can iron chelators ameliorate viral infections?
Pereira, T. A., & Espósito, B. P. (2023) · BioMetals · doi:10.1007/s10534-023-00558-x · Cited by 1
“( 1234567890) of hepcidin proportional to the decrease of CD4 count in seropositive patients (Armitage et al. 2014; Drakesmith and Prentice 2008; Garrido-Rodríguez et al. 2022; Wisaksana et al. 2013).”
Yakovleva, E. (2022) · The Bulletin of Contemporary Clinical Medicine · doi:10.20969/vskm.2022.15(1).88-94
A study of an Incidence of tuberculosis is linked to elevated hepcidin at HIV diagnosis
Saxena, P., Kumar, S. M., & Pooja, P. (2023) · Cardiometry · doi:10.18137/cardiometry.2022.25.14411443
Syamsul, F., Katu, S., Benyamin, A., Bakri, S., Aman, A., & Seweng, A. (2025) · Gazzetta Medica Italiana Archivio per le Scienze Mediche · doi:10.23736/s0393-3660.24.05676-6
Metadata
- Authors
- Wisaksana, R., de Mast, Q., Alisjahbana, B., Jusuf, H., Sudjana, P., Indrati, A. R., Sumantri, R., Swinkels, D., van Crevel, R., & van der Ven, A.
- Affiliations
- Dr. Hasan Sadikin General Hospital (ID)
- Radboud University Medical Center (NL)
- Corresponding author
- Wisaksana, Rudi
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-11-11
- Volume
- 8
- Issue
- 11
- Pages
- e79904
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3823592
- OpenAlex
- W2115980353
- Cited by
- 35
- References
- 38
- Citations by year
- 2025: 3 · 2024: 1 · 2023: 4 · 2022: 4 · 2021: 2 · 2020: 2 · 2019: 3 · 2018: 2 · 2017: 2 · 2015: 7 · 2014: 5
- FWCI
- 2.87
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Radboud Repository (Radboud University) (submittedVersion, other-oa)
- Funders
- Universitas Padjadjaran
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Immunology and Microbiology › Virology › HIV Research and Treatment
- Health Sciences › Medicine › Infectious Diseases › Tuberculosis Research and Epidemiology
- Keywords
- hepcidin, HIV infection, CD4 count, iron homeostasis, tuberculosis, hyperferritinemia, ferritin, hemoglobin, hepatitis C coinfection, iron metabolism, disease severity
- MeSH terms
- Adult, Antitubercular Agents, Female, Ferritins, Hemoglobins, Hepatitis C, Humans, Indonesia, Iron, Male, Prospective Studies, Tuberculosis, Pulmonary, CD4-Positive T-Lymphocytes, HIV Infections, Case-Control Studies, Disease Progression, CD4 Lymphocyte Count, Hepcidins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.
